Uniphos Enterprises Limited (UNIENTER) AI Stock Analysis

0 Followers

Uniphos Enterprises Limited

(NSE:UNIENTER)

Select Model

Rating:50Neutral

Price Target:INR 86.00▼(-6.98% Downside)

Action:reiterated

Date:10/27/26

The score is constrained primarily by weak and low-quality operating earnings, shrinking revenue, and inconsistent cash generation. The debt-free balance sheet and dividend yield provide support, but bearish technical positioning and a relatively high P/E limit the overall score.

Positive Factors

Debt-free balance sheetA debt-free balance sheet materially lowers financial risk by avoiding mandatory interest and principal payments. This gives Uniphos greater flexibility to withstand weak trading conditions, preserve liquidity, and potentially fund working-capital needs without relying on external borrowing.

Negative Factors

Sharp revenue contractionA sharp recent revenue contraction, combined with earlier volatility, weakens visibility into demand and makes future earnings harder to plan. For a chemical trading business, unstable sales can reduce purchasing leverage, impair fixed-cost absorption, and limit the predictability of cash generation.

Uniphos Enterprises Limited (UNIENTER) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 6.59B
Dividend Yield: 3.77%
Average Volume (3M): 609
Price to Earnings (P/E): 30.6
Beta (1Y): 1.12
Revenue Growth: -77.13%
EPS Growth: ―
Country: India
Employees: 2,022
Sector: General
Sector Strength: 55
Industry: Chemicals

Uniphos Enterprises Limited Business Overview & Revenue Model

Company Description

Uniphos Enterprises Limited, primarily operating in India, is involved in the trade of chemical products and various other goods. It also makes investments in both publicly listed and unlisted securities. The company was founded in 1969 and has its c...

How the Company Makes Money

UNIENTER primarily makes money through the sale of chemicals sourced from manufacturers and sold onward to customers, earning revenue from the invoiced value of goods sold. Its core revenue model is therefore trading/distribution: the company buys ch...

Uniphos Enterprises Limited Financial Statement Overview

Summary

A debt-free, liquid balance sheet is a relative strength, but the company has shrinking revenue, consistently negative operating performance, questionable earnings quality, and volatile cash flow.

Income Statement

38Negative

Balance Sheet

72Positive

Cash Flow

45Neutral

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	263.09M	320.03M	1.12B	506.48M	14.72M	12.22M
Gross Profit	-4.64M	-18.27M	8.02M	652.00K	164.00K	-11.00K
EBITDA	210.40M	215.10M	22.99M	-30.90M	-28.63M	-31.26M
Net Income	202.57M	207.11M	2.78M	386.14M	392.25M	546.04M
Balance Sheet
Total Assets	0	26.19B	28.42B	20.78B	30.95B	33.02B
Cash, Cash Equivalents and Short-Term Investments	203.54M	209.51M	162.37M	469.95M	517.30M	391.46M
Total Debt	0	0	0	0	0	0
Total Liabilities	-24.47B	1.72B	1.00B	20.50M	978.68M	1.21B
Stockholders Equity	24.47B	24.47B	27.42B	20.75B	29.98B	31.81B
Cash Flow
Free Cash Flow	-20.75M	0	-27.17M	-34.67M	-14.66M	5.20M
Operating Cash Flow	-20.75M	213.92M	-27.17M	-34.67M	-14.66M	5.20M
Investing Cash Flow	65.05M	-148.99M	527.70M	501.62M	406.29M	204.34M
Financing Cash Flow	-34.77M	-34.77M	-409.58M	-452.05M	-392.93M	-236.46M

Uniphos Enterprises Limited Technical Analysis

Technical Analysis SentimentPositive

Last Price92.45

Price Trends

50DMA89.64Positive

100DMA95.27Negative

200DMA100.64Negative

Market Momentum

MACD-0.44Negative

RSI58.57Neutral

STOCH71.48Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:UNIENTER, the sentiment is Positive. The current price of 92.45 is above the 20-day moving average (MA) of 86.12, above the 50-day MA of 89.64, and below the 200-day MA of 100.64, indicating a neutral trend. The MACD of -0.44 indicates Negative momentum. The RSI at 58.57 is Neutral, neither overbought nor oversold. The STOCH value of 71.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:UNIENTER.

Uniphos Enterprises Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:UNIENTER against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:INDOAMIN	76Outperform	INR 9.00B	11.66	―	0.38%	13.23%	22.22%
IN:PUNJABCHEM	68Neutral	INR 10.92B	18.59	―	0.33%	13.95%	15.36%
IN:AMNPLST	66Neutral	INR 7.78B	20.88	―	0.34%	-12.40%	-3.04%
IN:VALIANTORG	64Neutral	INR 11.75B	22.48	―	―	1.41%	946.41%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:DMCC	53Neutral	INR 5.85B	16.09	―	1.03%	72.14%	34.49%
IN:UNIENTER	50Neutral	INR 6.33B	30.64	―	3.77%	-77.13%	―

* General Sector Average

Performance Comparison

IN:UNIENTER and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:UNIENTER	Uniphos Enterprises Limited	92.45	-52.87	-36.38%
IN:AMNPLST	Amines & Plasticizers Ltd.	149.50	-57.38	-27.73%
IN:DMCC	DMCC Speciality Chemicals Limited	241.20	-49.64	-17.07%
IN:INDOAMIN	Indo Amines Limited	129.90	-2.86	-2.16%
IN:PUNJABCHEM	Punjab Chemicals & Crop Protection Ltd.	919.35	-347.97	-27.46%
IN:VALIANTORG	Valiant Organics Limited	433.15	130.20	42.98%

Uniphos Enterprises Limited Corporate Events

Uniphos Enterprises Reports Q1 FY27 Unaudited Loss Amid Volatile Comprehensive Income

Aug 14, 2026

Uniphos Enterprises Limited, an exchange-listed Indian company headquartered in Gujarat with corporate offices in Mumbai, reported its unaudited financial results for the quarter ended June 30, 2026. The firm’s equity is traded on BSE and NSE,...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 27, 2026

Uniphos Enterprises Limited AI Stock Analysis